Unknown

Dataset Information

0

Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase.


ABSTRACT: Mutations in isocitrate dehydrogenase (IDH), a key enzyme in the tricarboxylic acid cycle, have recently been found in ~75% glioma and ~20% acute myeloid leukemia. Different from the wild-type enzyme, mutant IDH1 catalyzes the reduction of α-ketoglutaric acid to D-2-hydroxyglutaric acid. Strong evidence has shown mutant IDH1 represents a novel target for this type of cancer. We found two 1-hydroxypyridin-2-one compounds that are potent inhibitors of R132H and R132C IDH1 mutants with Ki values as low as 120 nM. These compounds exhibit >60-fold selectivity against wild-type IDH1 and can inhibit the production of D-2-hydroxyglutaric acid in IDH1 mutated cells, representing novel chemical probes for cancer biology studies. We also report the first inhibitor-bound crystal structures of IDH1(R132H), showing these inhibitors have H-bond, electrostatic and hydrophobic interactions with the mutant enzyme. Comparison with the substrate-bound IDH1 structures revealed the structural basis for the high enzyme selectivity of these compounds.

SUBMITTER: Zheng B 

PROVIDER: S-EPMC3686309 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4384718 | biostudies-literature
| S-EPMC4294499 | biostudies-literature
| S-EPMC6699636 | biostudies-literature
| S-EPMC6534082 | biostudies-literature
| S-EPMC8560763 | biostudies-literature
| S-EPMC9549919 | biostudies-literature
| S-EPMC4207540 | biostudies-literature
| S-EPMC2242954 | biostudies-literature
| S-EPMC5885269 | biostudies-literature
| S-EPMC9825307 | biostudies-literature